Accelerate Diagnostics
AXDX
$0.93
Share price
-0.59%
Change (1 day)
3.34%
Change (1 year)
Categories
Accelerate Diagnostics (AXDX) - Total debt
Total debt on the balance sheet as of September 2023 : $36.57 M
According to Accelerate Diagnostics's latest financial reports the company's total debt is $36.57 M. A company’s total debt is the sum of all current and non-current debts.
Accelerate Diagnostics - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $77.54 M | -30.22% |
| 2021-12-31 | $0.11 B | -25.92% |
| 2020-12-31 | $0.14 B | 11.87% |
| 2019-12-31 | $0.13 B | 11.66% |
| 2018-12-31 | $0.12 B | |
| 2016-12-31 | $N/A | -100% |
| 2015-12-31 | $0.01 M | -91.88% |
| 2014-12-31 | $0.16 M | |
| 2013-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $34.91 B | 95,379.90% | 🇺🇸 USA |
 Becton Dickinson BDX | $16.11 B | 43,952.50% | 🇺🇸 USA |
 PerkinElmer
PKI | $4.50 B | 12,231.97% | 🇺🇸 USA |
 Bruker BRKR | $1.37 B | 3,672.49% | 🇺🇸 USA |
 NanoString Technologies NSTG | $0.24 B | 577.34% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $1.40 B | 3,743.15% | 🇺🇸 USA |